Releases·Agent Release
The Virtual Biotech: A 37,000 AI agent organization for therapeutic discovery and development
The Virtual Biotech: A 37,000 AI agent organization for therapeutic discovery and development
7 engagement1 sourceTue, Sep 22, 2026, 07:39 PM
AI Overview
- A study on science.org describes a "virtual biotech" built from 37,000 AI agents for therapeutic discovery and development.
- The Reddit post linking the study drew 7 upvotes.
- The study was published 2026-09-22.
Entities
Related
Developments·Paper
Can AI Be a Scientist? Inside Stanford's 37,000-Agent Virtual Biotech
A paper in Science, covered in a Medium writeup, describes a simulated drug company staffed entirely by software agents — 37,000 of them. The article examines what the virtual biotech demonstrated and what press coverage omitted. For AI practitioners, it is a large-scale test of agent organization on a real scientific domain.
A paper in Science, covered in a Medium writeup, describes a simulated drug company staffed entirely by software agents — 37,000 of them. The article examines what the virtual biotech demonstrated and what press coverage omitted. For AI practitioners, it is a large-scale test of agent organization on a real scientific domain.
0 engagement1 sourcerssMon, Oct 12, 2026, 04:31 AM
Social·Community
AI agents searched 55,000 trials, an AI-designed pulmonary fibrosis drug entered Phase III, and an autonomous medical agent emerged in 100 days
AI in medicine roundup: 37,000 agents search 55,000 trials, AI-designed drug reaches Phase III
AI in medicine roundup: 37,000 agents search 55,000 trials, AI-designed drug reaches Phase III
1.6k engagement1 sourceredditFri, Sep 25, 2026, 07:11 PM
Products·concept
Virtual biotech company run by tens of thousands of AI scientist agents for drug discovery
Stanford Medicine researchers and colleagues built a virtual biotech company staffed by tens of thousands of AI agents, each trained on a different aspect of drug development. The LLM-powered agents collaborate to carry out drug discovery workflows that would normally require a full company of human specialists. It aims to speed up and reduce the cost of identifying drug candidates for researchers.
Stanford Medicine researchers and colleagues built a virtual biotech company staffed by tens of thousands of AI agents, each trained on a different aspect of drug development. The LLM-powered agents collaborate to carry out drug discovery workflows that would normally require a full company of human specialists. It aims to speed up and reduce the cost of identifying drug candidates for researchers.
0 engagement1 sourcemed.stanford.eduFri, Sep 18, 2026, 05:43 AM
Developments·Paper
Lab positions A.I. agents as 'co-scientists' to speed drug discovery, but says research is only a proof of concept
Lab presents AI agents as 'co-scientists' to speed drug discovery, framed as proof of concept
Lab presents AI agents as 'co-scientists' to speed drug discovery, framed as proof of concept
0 engagement1 sourcenytimes.comSun, Sep 20, 2026, 05:43 AM
Developments·Paper
Nature publishes overview of AI in drug discovery
A Nature article provides a comprehensive overview of AI in drug discovery, covering current methods, challenges, and future directions. The piece highlights the growing role of machine learning in target identification, molecule generation, and clinical trial design, and discusses the path toward broader adoption in the pharmaceutical industry.
A Nature article provides a comprehensive overview of AI in drug discovery, covering current methods, challenges, and future directions. The piece highlights the growing role of machine learning in target identification, molecule generation, and clinical trial design, and discusses the path toward broader adoption in the pharmaceutical industry.
263 engagement1 sourcehackernewsSat, Aug 15, 2026, 07:12 PM